Fig. 1
figure 1

The slow-release dexamethasone in proliferative vitreoretinopathy (PVR) prospective, randomized controlled clinical trial showed that a slow-release Dexamethasone injection given at the time of vitrectomy surgery and repeated at the time of oil removal does not increase the anatomic success rate at 6 months in eyes with rhegmatogenous retinal detachment with grade C PVR. There was also no change in visual acuity, however there was a statistical reduction in cystoid macular oedema. CI confidence interval.

Reference to original study: Banerjee, P. et al., 2017. Slow-Release Dexamethasone in Proliferative Vitreoretinopathy. Ophthalmology, 124(6), pp.757–767.